Profile
NRXS VRTX REGN VRNA ARGX ALNY
Company Name NeurAxis, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $49.54M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.02K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Brian Carrico Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
NRXS VRTX REGN VRNA ARGX ALNY
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
NRXS VRTX REGN VRNA ARGX ALNY
Last Close $2.31 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $3.93 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $1.6 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -41.22 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 44.38 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
NRXS VRTX REGN VRNA ARGX ALNY
1 Month Return -23.76 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -6.85 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 2.67 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -0.43 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -1.7 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -28.92 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
NRXS VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -247.42 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
NRXS VRTX REGN VRNA ARGX ALNY
Asset Growth 833.78 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth 7.75 % 1.16 % - 26.81 %
Revenue Growth 9.18 % 0.99 % - 22.97 %
Revenue 3 Year -23.22 % 20.64 % -15.89 % 147.1 %
Revenue 5 Year 8.25 % 73.64 % - 775.72 %
Revenue 10 Year 8.25 % 285.02 % - 2487.4 %
EBIT Growth 14.33 % 9.09 % -131.37 % 24.59 %
Net Income Growth 43.65 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share -111.74 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share -72.07 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -72.07 % 680.22 % -35.51 % 55.09 %
Operating Income Growth -7.39 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) 8.9 % - -143.33 % -107.98 %
Operating 3 Year CFG -112.33 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG -14.61 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -14.61 % -100 % 40.15 % 97.08 %
EPS Growth 47.41 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 47.41 % 8.19 % -208.93 % 38.07 %
Book Value Per Share 234.1 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share 294.83 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -2.14 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share -2.14 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth 111.1 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth 9.46 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
NRXS VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 84.34 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -130.53 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -340.23 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -288.29 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 99.47 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -225.43 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -1307.8 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 30.99 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.59 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM 4.78 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 927.05 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 58.21 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.63 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.64 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 44.31 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -186.09 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.4 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -1307.8 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -7.89 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -7.34 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -7.34 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
NRXS VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 86.52% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.01B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.01B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -1.22 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
NRXS VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
NRXS VRTX REGN VRNA ARGX ALNY
Net Income $-0.01B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $-0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.6
AARD Aardvark Therapeutics, Inc. Common Stock 12.67
ABCL AbCellera Biologics Inc. 3.135
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.06
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.56
ABPWW 0.0133
ABSI Absci Corporation 2.6
ABUS Arbutus Biopharma Corporation 4.16
ABVC ABVC BioPharma, Inc. 1.73
ABVX Abivax SA American Depositary Shares 122.77
ACAD ACADIA Pharmaceuticals Inc. 22.47
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.81
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.28
ACIU AC Immune SA 3.03
ETFs With Exposure to NRXS
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00001 341.47
VXF Vanguard Extended Market Index Fund 0.00028 218.1
VUN.TO Vanguard U.S. Total Market Index ETF 0.00001 126.01
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00001 118.61
VGRO.TO Vanguard Growth ETF Portfolio 0 44.38
VEQT.TO Vanguard All-Equity ETF Portfolio 0 55.86
VBAL.TO Vanguard Balanced ETF Portfolio 0 37.88
VCNS.TO Vanguard Conservative ETF Portfolio 0 32.13
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.34
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 26.99
VTSAX Vanguard Total Stock Market Index Fund 0.00001 166.24
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00028 165.55
VITSX Vanguard Total Stock Market Index Fund 0.00001 166.27
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00028 165.56
VTS.AX Vanguard US Total Market Shares Index ETF 0.00001 481.52
VEMPX Vanguard Extended Market Index InstlPlus 0.00028 408.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00001 311.9
Unlock